FDA Approved: VYXEOS — Supplemental Application (Jazz Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for VYXEOS (daunorubicin and cytarabine) liposome from Jazz Pharmaceuticals to support its use in acute myeloid leukemia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Vyxeos (CPX-351)

Snippet

SUPPL AP for VYXEOS ((DAUNORUBICIN AND CYTARABINE) LIPOSOME)